Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
EU Clears Arsenal's Buy of DSM Unit
by Marc S. Reisch
January 19, 2009
| A version of this story appeared in
Volume 87, Issue 3
European antitrust officials have cleared Arsenal Capital Partners' acquisition of DSM's special products business nine months after the two firms penned the deal. Because Arsenal controls Velsicol Chemical, the acquisition would have given Arsenal control of the only two European plants for benzoic acid-based food and drink preservatives. To get the deal done, Arsenal agreed to sell Velsicol's benzoic acid plant in Estonia. Separately, the European Commission cleared Dow Chemical's pending acquisition of Rohm and Haas. The U.S. government still must clear the deal.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter